QVA Mechanistic Efficacy Study (Receptor Effects, Etc)

NCT02634983 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: QVA149
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals